Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Change in Receivables: 2019-2024

Historic Change in Receivables for Cellebrite DI (CLBT) over the last 6 years, with Dec 2024 value amounting to $5.8 million.

  • Cellebrite DI's Change in Receivables rose 49.24% to -$11.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 106.42%. This contributed to the annual value of $5.8 million for FY2024, which is 356.67% up from last year.
  • Latest data reveals that Cellebrite DI reported Change in Receivables of $5.8 million as of FY2024, which was up 356.67% from -$2.3 million recorded in FY2023.
  • Cellebrite DI's 5-year Change in Receivables high stood at $19.7 million for FY2020, and its period low was -$2.3 million during FY2023.
  • Moreover, its 3-year median value for Change in Receivables was $5.8 million (2024), whereas its average is $5.5 million.
  • Its Change in Receivables has fluctuated over the past 5 years, first soared by 558.07% in 2022, then slumped by 117.63% in 2023.
  • Cellebrite DI's Change in Receivables (Yearly) stood at $19.7 million in 2020, then tumbled by 90.08% to $2.0 million in 2021, then surged by 558.07% to $12.9 million in 2022, then slumped by 117.63% to -$2.3 million in 2023, then skyrocketed by 356.67% to $5.8 million in 2024.